The COPD Patient Management European Trial (COMET)
Launched by AIR LIQUIDE SANTÉ INTERNATIONAL · Nov 15, 2010
Trial Information
Current as of May 28, 2025
Completed
Keywords
ClinConnect Summary
Primary objective: To evaluate a strategy of Chronic Obstructive Pulmonary Disease (COPD) management to reduce the number of hospital days in patients with severe Gold III/IV COPD: a Home-Based COPD Management Program versus usual patient education and follow-up.
Secondary objectives:
* To assess the clinical outcome and the health-related quality of life,
* To assess safety,
* To evaluate medico-economic impact.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Confirmed Gold III/IV COPD
- • Current or ex-smoker with a smoking history ≥ 10 pack-years
- • At least one COPD exacerbation leading to hospitalization in the year before selection.
- Exclusion Criteria:
- • LTOT for another reason than COPD
- • Severe concomitant disorder associated with a limited probability of survival (\< 6 months)
- • Tracheostomy
- • Long term oral corticosteroids therapy
About Air Liquide Santé International
Air Liquide Santé International is a leading global provider of healthcare solutions, specializing in the delivery of medical gases, home healthcare services, and innovative therapeutic solutions. With a commitment to improving patient outcomes and quality of life, the organization focuses on developing and supporting clinical trials that advance medical knowledge and foster the safe use of its products. Leveraging its extensive expertise in respiratory care and critical care, Air Liquide Santé International collaborates with healthcare professionals and institutions to drive research initiatives, ensuring adherence to the highest standards of safety and efficacy in the healthcare sector.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Madrid, , Spain
Macerata, , Italy
Valencia, , Spain
Paris, , France
Grenoble, , France
Schmallenberg, , Germany
Lyon, , France
Hemer, , Germany
Le Mans, , France
Heidelberg, , Germany
Paris, , France
Antibes, , France
Colmar, , France
Marseille, , France
Metz, , France
Paris Cedex 14, , France
Strasbourg, , France
Thionville, , France
Toulon, , France
Kassel, Hesse, Germany
Aachen, , Germany
Hagen, , Germany
Solingen, , Germany
Ulm, , Germany
Bussolengo, , Italy
Civita Castellana, , Italy
Milano, , Italy
Milan, , Italy
Seregno, , Italy
Burgos, , Spain
Caceres, , Spain
Madrid, , Spain
Oviedo, , Spain
Patients applied
Trial Officials
Romain KESSLER, MD
Study Chair
Hopital Civil de Strasbourg - France
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials